ALFR.Y Stock Overview
Through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Alfresa Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥13.42 |
| 52 Week High | JP¥13.42 |
| 52 Week Low | JP¥13.42 |
| Beta | 0.22 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -42.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| ALFR.Y | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | 1.2% |
| 1Y | n/a | 6.9% | 27.7% |
Return vs Industry: Insufficient data to determine how ALFR.Y performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how ALFR.Y performed against the US Market.
Price Volatility
| ALFR.Y volatility | |
|---|---|
| ALFR.Y Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: ALFR.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ALFR.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 11,925 | Ryuji Arakawa | www.alfresa.com |
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies.
Alfresa Holdings Corporation Fundamentals Summary
| ALFR.Y fundamental statistics | |
|---|---|
| Market cap | US$2.42b |
| Earnings (TTM) | US$217.25m |
| Revenue (TTM) | US$18.18b |
11.2x
P/E Ratio0.1x
P/S RatioIs ALFR.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALFR.Y income statement (TTM) | |
|---|---|
| Revenue | JP¥2.60t |
| Cost of Revenue | JP¥2.41t |
| Gross Profit | JP¥186.60b |
| Other Expenses | JP¥155.53b |
| Earnings | JP¥31.06b |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Nov 07, 2022
| Earnings per share (EPS) | 153.50 |
| Gross Margin | 7.18% |
| Net Profit Margin | 1.20% |
| Debt/Equity Ratio | 0.006% |
How did ALFR.Y perform over the long term?
See historical performance and comparison